Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02980887 · ClinicalTrials.gov registry record
Pulmonary Vascular Disease Phenomics Program PVDOMICS
A clinical trial of Pulmonary Arterial Hypertension, sponsored by The Cleveland Clinic.
- Active
- Registry status
- 1,195
- Enrollment target
- 7
- Study locations
NCT02980887 is a study of Pulmonary Arterial Hypertension that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 1,195 participants, above the 443-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (170% higher). The trial reports 7 study locations across 6 states.
The verdict
NCT02980887, a study of Pulmonary Arterial Hypertension, is active but no longer recruiting, sponsored by The Cleveland Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 1,195 participants
- Enrollment target
- 7
- Study locations
Study Summary
It is recognized that patients with various forms of heart and lung disease exhibit varying degrees of pulmonary hypertension, pulmonary vascular remodeling, and right ventricular dysfunction. The genetic, molecular, and cellular processes driving these phenomena are not well understood. Rapid advances in high throughput omic methodology, combined with powerful bioinformatics and network biology capability, have created the opportunity to conduct studies that broadly search for homologies and differences across the spectrum of disease states associated with pulmonary hypertension, and determinants of the spectrum of right ventricular compensation that accompanies these conditions
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (7)
New York
- Weill Cornell Medicine - New York
- New York Medical College - Valhalla
Arizona
- University of Arizona Health Sciences Center - Tucson
Maryland
- Johns Hopkins University School of Medicine - Baltimore
Massachusetts
- Brigham and Women's Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,195 participants |
| Start Date | 2016-11 |
| Est. Completion | 2029-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02980887
The ClinicalTrials.gov registry entry for NCT02980887 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,195 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 443-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (170% higher). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Arterial Hypertension appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT02980887 reports 7 study locations spanning 6 distinct geographic areas - top geographies include New York, Arizona, Maryland.
Frequently Asked Questions
What is clinical trial NCT02980887 about?
NCT02980887 is a clinical study titled "Pulmonary Vascular Disease Phenomics Program PVDOMICS". It is recognized that patients with various forms of heart and lung disease exhibit varying degrees of pulmonary hypertension, pulmonary vascular remodeling, and right ventricular dysfunction. The genetic, molecular, and cellular processes driving these phenomena are not well understood. Rapid advan...
What is the current status of trial NCT02980887?
This trial is currently active not recruiting. The enrollment target is 1,195 participants. The study started on 2016-11. Estimated completion is 2029-12-31.
What conditions does trial NCT02980887 study?
This clinical trial studies the following conditions: Pulmonary Arterial Hypertension.
What interventions are being tested in trial NCT02980887?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02980887?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02980887 being conducted?
This trial has 7 study locations across Arizona, Maryland, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Arterial Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
RECRUITING · NA
-
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
RECRUITING · Phase 3
-
A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension
RECRUITING · Phase 1
-
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
RECRUITING · Phase 2
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.